These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse. Sterling RK; Smith PG; Brunt EM J Clin Gastroenterol; 2013 Feb; 47(2):182-7. PubMed ID: 23059409 [TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease and HIV infection. Vallet-Pichard A; Mallet V; Pol S Semin Liver Dis; 2012 May; 32(2):158-66. PubMed ID: 22760655 [TBL] [Abstract][Full Text] [Related]
4. From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management. Lemoine M; Serfaty L; Capeau J Curr Opin Infect Dis; 2012 Feb; 25(1):10-6. PubMed ID: 22183113 [TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease. Guaraldi G; Lonardo A; Ballestri S; Zona S; Stentarelli C; Orlando G; Carli F; Carulli L; Roverato A; Loria P Arch Med Res; 2011 Nov; 42(8):690-7. PubMed ID: 22227046 [TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease and steatohepatitis in people living with HIV. Squillace N; Soria A; Bozzi G; Gori A; Bandera A Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):643-650. PubMed ID: 31081390 [No Abstract] [Full Text] [Related]
8. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis. Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666 [TBL] [Abstract][Full Text] [Related]
15. Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV. Rockstroh JK Curr HIV/AIDS Rep; 2017 Apr; 14(2):47-53. PubMed ID: 28284005 [TBL] [Abstract][Full Text] [Related]
16. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients. Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832 [TBL] [Abstract][Full Text] [Related]
17. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841 [TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Dietrich P; Hellerbrand C Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181 [TBL] [Abstract][Full Text] [Related]
19. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. Patton HM; Sirlin C; Behling C; Middleton M; Schwimmer JB; Lavine JE J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):413-27. PubMed ID: 17033514 [TBL] [Abstract][Full Text] [Related]